ADVERTISEMENT

Quezon City congressional hopeful denies links to Pharmally Pharmaceutical

Published Dec 2, 2024 01:04 am

At A Glance

  • Aspiring Quezon City congresswoman Rose Nono-Lin has once again denied any links to the controversial Pharmally Pharmaceutical Corp., which is the subject of an ongoing investigation by the House quad-committee.

FB_IMG_1733100783527.jpgRose Nono-Lin (Facebook)

Aspiring Quezon City congresswoman Rose Nono-Lin has once again denied any links to the controversial Pharmally Pharmaceutical Corp., which is the subject of an ongoing investigation by the House quad-committee.

Nono-Lin is the owner of the now-defunct Pharmally Biological and Pharmaceutical Company. She says she is neither an official nor a shareholder of Pharmally Pharmaceutical Corp.

She reiterated that Pharmally Biological was separate and different from Pharmally Pharmaceutical, despite the namesake.

Nono-Lin also issued a similar clarification before the Senate Blue Ribbon Committee in 2021 when it investigated the P8-billion contract bagged by Pharmally Pharmaceutical for the provision of medical supplies to the previous Duterte government’s Covid-19 response efforts even as the firm had only P625,000 in paid-up capital.

"I have no involvement in the operations of Pharmally Pharmaceutical Corp. Pharmally Biological is a different entity, and has no shares or stocks with Pharmally Pharmaceutical," Nono-Lin pointed out.

"I am just an ordinary citizen and businesswoman making a living in a legal and fair means. All the accusations against me and my family were purely hearsay," added the businesswoman, who is eyeing the 5th district House seat.

Documents showed that Nono-Lin's husband, Lin Wei Xiong--a Chinese national--was the financial manager of Pharmally Pharmaceutical. He was a close associate of former presidential adviser Michael Yang, who provided the financing to the company.

Nono-Lin's lawyers pointed out though that these documents did not prove that Pharmally Biological and Pharmally Pharmaceutical were sister companies, or that Lin was an official or shareholder of the latter or has a contract with the government.

While it was acknowledged that Lin’s husband and Yang were partners in some activities, Nono-Lin's counsel argued that it did not prove anything.

“All these are speculations. She is not an officer [of Pharmally Pharmaceutical] nor involved in the operation or implementation of the contract,” Nono-Lin's counsel further said.

Related Tags

Pharmally Pharmaceutical Rose Nono Lin
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.